Shorting has always been a problem for AMBS. We have not had any sort of real partnership to move trials, just fluff PR's and the possibility of the next conference.
Hopefully they have the news to make shorts pay. Fingers crossed
(8)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
